Your browser doesn't support javascript.
loading
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.
Bergen, Elisabeth; Berghoff, Anna S; Rudas, Margaretha; Dubsky, Peter; De Vries, Catharina; Sattlberger, Claudia; Mader, Robert M; Zagouri, Flora; Sparber, Cornelia; Fitzal, Florian; Gnant, Michael; Rottenfusser, Andrea; Zielinski, Christoph C; Preusser, Matthias; Steger, Guenther G; Bartsch, Rupert.
Afiliação
  • Bergen E; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Berghoff AS; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Rudas M; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Pathology, Medical University of Vienna, Austria.
  • Dubsky P; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Surgery, Medical University of Vienna, Austria.
  • De Vries C; Department of Radiotherapy, LKH Feldkirch, Austria.
  • Sattlberger C; Department of Radiotherapy, LKH Feldkirch, Austria.
  • Mader RM; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, University of Athens, Greece.
  • Sparber C; Department of Medicine, LKH Kirchdorf, Austria.
  • Fitzal F; Department of Surgery, KH Barmherzigen Schwestern Linz, Austria.
  • Gnant M; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Surgery, Medical University of Vienna, Austria.
  • Rottenfusser A; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Radiotherapy, Medical University of Vienna, Austria.
  • Zielinski CC; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Preusser M; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Steger GG; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
  • Bartsch R; Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Austria.
Breast Care (Basel) ; 9(5): 344-8, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25759615

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article